03/14/2026
The FDA has expanded approval of Addyi for postmenopausal women up to age 65 with hypoactive sexual desire disorder. 🌸
Low libido after menopause is real and can be distressing for many women. It is important to understand that Addyi works on brain chemistry, carries specific safety warnings, and is not appropriate for everyone. Thoughtful evaluation, discussion of risks and benefits, and individualized care always come first.
Women deserve evidence based options and honest conversations about sexual health at every stage of life.
📅 Schedule your next wellness visit today. (727) 376-1536
🌸